JAZZbenzinga

Piper Sandler Reiterates Overweight on Jazz Pharmaceuticals, Lowers Price Target to $147

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 7, 2025 by benzinga

    Piper Sandler Reiterates Overweight on Jazz Pharmaceuticals, Lowers Price Target to $147 | JAZZ Stock News | Candlesense